Home/Werewolf Therapeutics/Chulho Park, Ph.D.
CP

Chulho Park, Ph.D.

Senior Vice President, Translational Sciences

Werewolf Therapeutics

Therapeutic Areas

Werewolf Therapeutics Pipeline

DrugIndicationPhase
WTX-124Advanced or metastatic solid tumorsPhase 1
WTX-330Advanced or metastatic solid tumors / non-Hodgkin lymphomaPhase 1
WTX-518UndisclosedPreclinical
WTX-712UndisclosedPreclinical